Atlas Trials

Study to Assess the Safety of MRx0029 or MRx0005 Compared to Placebo, in People With Parkinson's

Clinical trial NCT05832775 · WITHDRAWN

Trial details

NCT number
NCT05832775
Sponsor
4D pharma plc
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Idiopathic Parkinson Disease
Start date
2022-05-01
Primary completion
2023-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.